MIRO - Miromatrix Medical Inc. Stock Price, Fair Value and News

$3.39

Market Closed as of 22 Dec 2023, 04:00 pm ET

MIRO Stock Valuation Analysis

Valuation

Max Portfolio %

MIRO Price Action

MIRO RSI Chart

MIRO Stock Valuation Analysis

Valuation

Max Portfolio %

MIRO Valuation

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MIRO Fundamentals

MIRO Revenue

MIRO Earnings

MIRO Profitability

MIRO Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

Net sales

Year	Q1	Q2	Q3	Q4
2023	-	-	-	-
2022	33.7K	28.5K	31.1K	953.5K
2021	43.2K	39.8K	36.4K	33.1K
2020	-	-	-	46.5K

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Miromatrix Medical Inc.

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

CEO	Dr. Jeffrey James Ross Ph.D.
WEBSITE	miromatrix.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	76